Impact on length of stay and readmission rates when converting oral to long-acting injectable antipsychotics in schizophrenia or schizoaffective disorder

INTRODUCTION: Nonadherence with oral antipsychotics in patients with schizophrenia has been associated with symptom relapse and rehospitalizations, resulting in increased morbidity and health care costs. Long-acting injectable antipsychotics (LAIAs) are an alternative to enhance adherence and decrea...

Descripción completa

Detalles Bibliográficos
Autores principales: Chou, Fabienne, Reome, Earle, Davis, Patricia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: College of Psychiatric & Neurologic Pharmacists 2016
Materias:
Open Submissions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007588/
https://www.ncbi.nlm.nih.gov/pubmed/29955479
http://dx.doi.org/10.9740/mhc.2016.09.254

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007588/
https://www.ncbi.nlm.nih.gov/pubmed/29955479
http://dx.doi.org/10.9740/mhc.2016.09.254

Ejemplares similares